HOME /

News

HSCI faculty member appointed the inaugural Regenerative Biology Endowed Chair at Boston Children’s Hospital

March 4, 2022

Fernando Camargo recognized for pioneering scientific contributions and outstanding leadership

Fernando Camargo, Ph.D., has been named as the inaugural Regenerative Biology Endowed Chair by the Boston Children’s Hospital (BCH) Department of Pediatrics, in recognition of his pioneering scientific contributions and outstanding leadership. Camargo is a professor in the Harvard Department of Stem Cell and Regenerative Biology (HSCRB) and Harvard Medical School (HMS)...

Read more about HSCI faculty member appointed the inaugural Regenerative Biology Endowed Chair at Boston Children’s Hospital

HSCI receives grant from the Crown Prince of Abu Dhabi to help advance type 1 diabetes research

February 8, 2022

Douglas Melton, Co-Director of the Harvard Stem Cell Institute (HSCI), has received a financial grant from His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi. The grant will bolster HSCI research focusing on accelerating gene editing approaches for pancreatic beta cell replacement therapy.

According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.6 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few...

Read more about HSCI receives grant from the Crown Prince of Abu Dhabi to help advance type 1 diabetes research

Call for Proposals: 2022 HSCI Cancer Program Pilot Grants

February 2, 2022

AWARD AMOUNT
Up to $100,000 for entire project period
Project period not to exceed 2 years

POSTED DATE
Wednesday, February 2, 2022

DEADLINE FOR APPLICATION
Friday, March 4,  2022

ANTICIPATED AWARD DATE
April  1, 2022

The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for pilot grants to be awarded for research in 2022. The intent is to provide resources for innovative projects dissecting stem/developmental programs in solid tumors that would help foster collaborations within the HSCI research community. This funding is for innovative, high-impact research projects. Multi-investigator, multi-institution proposals are encouraged; of specific interest to this funding cycle are proposals that dissect mechanisms that enable malignant stem cells to evade the immune system. Additionally, the applications should promote the Program mission: To identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence may serve as candidate targets for therapy.... Read more about Call for Proposals: 2022 HSCI Cancer Program Pilot Grants